Showing 1-7 of 7 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Acetazolamide and Tubuloglomerular Feedback in Persons with Type 1 Diabetes: A Clinical Trial | University of California, San Diego | Charles Ginsberg | Improving Lives | 01-November-2022 to 31-October-2026 | $1,356,726.45 |
| The Effects of Glucagon Antagonism on Insulin Resistance, Ketone Production, and Cardiovascular Risk in Individuals with Type 1 Diabetes | University of California, San Diego | Jeremy Pettus | Improving Lives | 01-June-2021 to 30-November-2026 | $1,233,752.52 |
| Microneedle Sensor for Simultaneous Continuous Monitoring of Ketone and Glucose | University of California, San Diego | Joseph Wang | Improving Lives | 01-October-2022 to 30-April-2027 | $867,998.91 |
| Reducing the Burden of Type 1 Diabetes Using Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances | University of California, San Diego | Schafer Boeder | Improving Lives | 01-July-2022 to 30-June-2027 | $749,956.58 |
| Identification of novel targets to increase human beta cell proliferation | The Regents of the University of California, San Francisco | Gregory Ku | Cures | 01-December-2020 to 31-August-2026 | $975,000.00 |
| Ultrafast Insulin-Pramlintide Co-formulations | Stanford University | Eric Appel | Improving Lives | 01-September-2022 to 31-December-2026 | $794,960.90 |
| Transcriptional memory in human islet organogenesis | Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) | Eiji Yoshihara | Cures | 01-April-2022 to 31-March-2027 | $749,995.50 |